Cargando…

4089 Clinical Implementation of Monte Carlo Dose Calculation for Patient-Specific Radiotherapy Quality Assurance

OBJECTIVES/GOALS: The Monte Carlo dose calculation method is often considered the “gold standard” for patient dose calculations and can be as radiation dose measurements. Our study aims to develop a true Monte Carlo model that can be implemented in our clinic as part of our routine patient-specific...

Descripción completa

Detalles Bibliográficos
Autores principales: Parenica, Holly Marie, Kabat, Christopher, Myers, Pamela, Kirby, Neil, Papaconstadopoulos, Pavlos, Papanikolaou, Nikos, Stathakis, Sotirios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822931/
http://dx.doi.org/10.1017/cts.2020.327
_version_ 1784646705933713408
author Parenica, Holly Marie
Kabat, Christopher
Myers, Pamela
Kirby, Neil
Papaconstadopoulos, Pavlos
Papanikolaou, Nikos
Stathakis, Sotirios
author_facet Parenica, Holly Marie
Kabat, Christopher
Myers, Pamela
Kirby, Neil
Papaconstadopoulos, Pavlos
Papanikolaou, Nikos
Stathakis, Sotirios
author_sort Parenica, Holly Marie
collection PubMed
description OBJECTIVES/GOALS: The Monte Carlo dose calculation method is often considered the “gold standard” for patient dose calculations and can be as radiation dose measurements. Our study aims to develop a true Monte Carlo model that can be implemented in our clinic as part of our routine patient-specific quality assurance. METHODS/STUDY POPULATION: We have configured and validated a model of one of our linear accelerators used for radiation therapy treatments using the EGSnrc Monte Carlo simulation software. Measured dosimetric data was obtained from the linear accelerator and was used as the standard to compare the doses calculated with our model in EGSnrc. We will compare dose calculations between commercial treatment planning systems, the EGSnrc Monte Carlo model, and patient-specific measurements. We will implement the Monte Carlo model in our clinic for routine second-checks of patient plans, and to recalculate plans delivered to patients using machine log files. RESULTS/ANTICIPATED RESULTS: Our Monte Carlo model is within 1% agreement with our measured dosimetric data, and is an accurate representation of our linear accelerators used for patient treatments. With this high level of accuracy, we have begun simulating more complex patient treatment geometries, and expect the level of accuracy to be within 1% of measured data. We believe the Monte Carlo calculation based on machine log files will correlate with patient-specific QA analysis and results. The Monte Carlo model will be a useful tool in improving our patient-specific quality assurance protocol and can be utilized in further research. DISCUSSION/SIGNIFICANCE OF IMPACT: This work can be implemented directly in clinical practice to ensure patient doses are calculated as accurately as possible. These methods can be used by clinics who do not have access to more advanced dose calculation software, ensuring accuracy for all patients undergoing radiotherapy treatments.
format Online
Article
Text
id pubmed-8822931
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-88229312022-02-18 4089 Clinical Implementation of Monte Carlo Dose Calculation for Patient-Specific Radiotherapy Quality Assurance Parenica, Holly Marie Kabat, Christopher Myers, Pamela Kirby, Neil Papaconstadopoulos, Pavlos Papanikolaou, Nikos Stathakis, Sotirios J Clin Transl Sci Precision Medicine OBJECTIVES/GOALS: The Monte Carlo dose calculation method is often considered the “gold standard” for patient dose calculations and can be as radiation dose measurements. Our study aims to develop a true Monte Carlo model that can be implemented in our clinic as part of our routine patient-specific quality assurance. METHODS/STUDY POPULATION: We have configured and validated a model of one of our linear accelerators used for radiation therapy treatments using the EGSnrc Monte Carlo simulation software. Measured dosimetric data was obtained from the linear accelerator and was used as the standard to compare the doses calculated with our model in EGSnrc. We will compare dose calculations between commercial treatment planning systems, the EGSnrc Monte Carlo model, and patient-specific measurements. We will implement the Monte Carlo model in our clinic for routine second-checks of patient plans, and to recalculate plans delivered to patients using machine log files. RESULTS/ANTICIPATED RESULTS: Our Monte Carlo model is within 1% agreement with our measured dosimetric data, and is an accurate representation of our linear accelerators used for patient treatments. With this high level of accuracy, we have begun simulating more complex patient treatment geometries, and expect the level of accuracy to be within 1% of measured data. We believe the Monte Carlo calculation based on machine log files will correlate with patient-specific QA analysis and results. The Monte Carlo model will be a useful tool in improving our patient-specific quality assurance protocol and can be utilized in further research. DISCUSSION/SIGNIFICANCE OF IMPACT: This work can be implemented directly in clinical practice to ensure patient doses are calculated as accurately as possible. These methods can be used by clinics who do not have access to more advanced dose calculation software, ensuring accuracy for all patients undergoing radiotherapy treatments. Cambridge University Press 2020-07-29 /pmc/articles/PMC8822931/ http://dx.doi.org/10.1017/cts.2020.327 Text en © The Association for Clinical and Translational Science 2020 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Precision Medicine
Parenica, Holly Marie
Kabat, Christopher
Myers, Pamela
Kirby, Neil
Papaconstadopoulos, Pavlos
Papanikolaou, Nikos
Stathakis, Sotirios
4089 Clinical Implementation of Monte Carlo Dose Calculation for Patient-Specific Radiotherapy Quality Assurance
title 4089 Clinical Implementation of Monte Carlo Dose Calculation for Patient-Specific Radiotherapy Quality Assurance
title_full 4089 Clinical Implementation of Monte Carlo Dose Calculation for Patient-Specific Radiotherapy Quality Assurance
title_fullStr 4089 Clinical Implementation of Monte Carlo Dose Calculation for Patient-Specific Radiotherapy Quality Assurance
title_full_unstemmed 4089 Clinical Implementation of Monte Carlo Dose Calculation for Patient-Specific Radiotherapy Quality Assurance
title_short 4089 Clinical Implementation of Monte Carlo Dose Calculation for Patient-Specific Radiotherapy Quality Assurance
title_sort 4089 clinical implementation of monte carlo dose calculation for patient-specific radiotherapy quality assurance
topic Precision Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822931/
http://dx.doi.org/10.1017/cts.2020.327
work_keys_str_mv AT parenicahollymarie 4089clinicalimplementationofmontecarlodosecalculationforpatientspecificradiotherapyqualityassurance
AT kabatchristopher 4089clinicalimplementationofmontecarlodosecalculationforpatientspecificradiotherapyqualityassurance
AT myerspamela 4089clinicalimplementationofmontecarlodosecalculationforpatientspecificradiotherapyqualityassurance
AT kirbyneil 4089clinicalimplementationofmontecarlodosecalculationforpatientspecificradiotherapyqualityassurance
AT papaconstadopoulospavlos 4089clinicalimplementationofmontecarlodosecalculationforpatientspecificradiotherapyqualityassurance
AT papanikolaounikos 4089clinicalimplementationofmontecarlodosecalculationforpatientspecificradiotherapyqualityassurance
AT stathakissotirios 4089clinicalimplementationofmontecarlodosecalculationforpatientspecificradiotherapyqualityassurance